Peridurography with metrizamide: animal and human studies

Radiology
|July 1, 1978
PubMed

Insights

Metrizamide (300 mg/ml) is a safe and effective contrast agent for spinal peridurography. This diagnostic procedure showed satisfactory radiographic contrast with no adverse effects in conscious dogs and humans.

Area of Science:

  • Radiology
  • Medical Imaging
  • Neuroradiology

Background:

  • Spinal peridurography is a diagnostic imaging technique.
  • Evaluating contrast agents for safety and efficacy is crucial.

Purpose of the Study:

  • To assess the safety and diagnostic utility of metrizamide for spinal peridurography.
  • To evaluate metrizamide's performance in conscious canine and human subjects.

Main Methods:

  • Metrizamide (300 mg/ml) was administered epidurally.
  • Evaluated for irritation, discomfort, radiographic contrast, and sequelae in dogs and humans.

Main Results:

  • Epidural metrizamide was non-irritating up to 12 ml volumes.
  • Larger volumes caused mild discomfort in two human patients.
  • Satisfactory radiographic contrast was achieved with no reported sequelae.

Conclusions:

  • Metrizamide (300 mg/ml) is a safe and useful contrast agent for spinal peridurography.
  • The procedure is well-tolerated in ambulant patients, offering diagnostic value.

Related Concept Videos